Journals / Viral Hepatitis Journal / 2017 / Cilt: 23 - Sayı: 2

Does Vitamin D Level Affect the Response to Antiviral Treatment in Egyptian Patients with Chronic Hepatitis C?

Kronik Hepatit C’li Mısırlı Hastalarda D Vitamini Düzeyi Antiviral Tedavi Cevabını Etkiler mi?

Pages
50–54
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Vitamin D levels could affect liver necro-inflammatory process in Egyptian patients with chronic hepatitis C infection, but did not show significant effect on response to antiviral therapy

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Vitamin D deficiency is common in patients with chronic liver disease.
📊
Key Findings & Data:Several studies demonstrated that its levels are inversely related to the disease severity and documented improvement of the disease following supplementation especially regarding to hepatitis C virus (HCV) infection.
💡
Conclusion & Impact:Conclusion: Vitamin D levels could affect liver necro-inflammatory process in Egyptian patients with chronic hepatitis C infection, but did not show significant effect on response to antiviral therapy
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Vitamin D deficiency is common in patients with chronic liver disease. Several studies demonstrated that its levels are inversely related to the disease severity and documented improvement of the disease following supplementation especially regarding to hepatitis C virus (HCV) infection. To study level of vitamin D in Egyptian patients with chronic HCV infection and to investigate its correlation with activity and fibrosis scores of their liver biopsies, as well as the relationship of vitamin D levels with patients’ response to antiviral therapy. Materials and Methods: The study included 60 Egyptian patients with chronic HCV infection who were scheduled for antiviral medications (pegylated-interferon and ribavirin) for 48 weeks and 50 healthy age- and sex-matched individuals non-reactive for HCV antibodies as a control group. Serum 25-hydroxyvitamin D was measured in all patients and controls and compared with patients’ liver biopsy results and their virological response (after 48 weeks treatment) assessed by polymerase chain reaction for HCV. Results: Serum vitamin D levels were inversely correlated with activity and fibrosis scores in liver biopsy. On the other hand, 63.3% of cases had good response to interferon treatment and 36.7% of them had no response without significant difference in serum vitamin D levels between responders and non-responders (39.2±23.6 and 37.1±13.2 ng/mL, respectively). Conclusion: Vitamin D levels could affect liver necro-inflammatory process in Egyptian patients with chronic hepatitis C infection, but did not show significant effect on response to antiviral therapy

Özet

Amaç: Kronik karaciğer hastalığı olanlarda D vitamini eksikliği yüksek prevalans göstermektedir. D vitamini düzeyleri hastalığın şiddeti ile ters ilişki göstermektedir. Girişimsel çalışmalar suplemantasyon sonrası kronik karaciğer hastalığında iyileşme raporlamaktadır. Benzer şekilde hepatit C virüs (HCV) enfeksiyonuna ilişkin sağlık durumunda düzelme bildirilmiştir. Kronik HCV enfeksiyonu olan Mısırlı hastalardaki vitamin D düzeyini belirlemek ve vitamin düzeyi ile karaciğer biyopsisi aktivite ve fibrozis skorları arasındaki ilişkiyi araştırmak, ayrıca antiviral tedaviye hastanın cevabı ile ilişkisini incelemektir. Gereç ve Yöntemler: Bu çalışma kronik HCV enfeksiyonu olan 60 Mısırlı hastada gerçekleştirilmiştir. Bu hastalar 48 hafta antiviral tedavi (pegile-interferon ve ribavirin) almıştır. Yaş ve cinsiyet uyumlu, HCV antikorları açısından reaktif olmayan 50 sağlıklı kişi de kontrol grubunu oluşturmuştur. Serum 25 hidroksivitamin D hem hastalar, hem de kontrol grubunda ölçülmüştür. Sonuçlar hastaların karaciğer biyopsi sonuçları ve HCV polimeraz zincir reaksiyonu ile değerlendirilen virolojik cevapları (48 haftalık tedavi sonrası) ile karşılaştırılmıştır. Bulgular: Serum D vitamini düzeyleri karaciğer biyopsisi aktivite ve fibrozis skorları ile ters ilişkili bulunmuştur. Olguların %63,3'ü interferon tedavisine iyi yanıt vermiştir. Tedaviye cevap ile vitamin D düzeyi ilişkisi ise korele bulunmamıştır (Tedaviye cevap veren ve vermeyen olgulardaki D vitamin düzeyi ortalamaları sırasıyla 39,2±23,6 ng/mL, 37,1±13,2 ng/mL).Sonuç: Kronik hepatit C enfeksiyonlu Mısırlı hastalarda D vitamini düzeyleri karaciğerin nekro-enflamatuvar süreçlerini etkilemiştir, ancak antiviral tedaviye cevap üzerinde anlamlı etkisi olmamıştır

🔖

Cite This Article

HUSSEIN, H. A., MOHAMAD, H. B., MASHAHEET, M. A., ALAMIR, M. A., EZZAT, G. M. (2017). Does Vitamin D Level Affect the Response to Antiviral Treatment in Egyptian Patients with Chronic Hepatitis C?. Viral Hepatitis Journal, Cilt: 23 - Sayı: 2, 50–54. https://ajindex.com/articles/332011

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Gal-tanamy M, Bachmetov L, Ravid A, Koren R, Erman A, Tur-Kaspa R, Zemel R. Vitamin D: an innate antiviral agent suppressing hepatitis C virus in human hepatocytes. Hepatology. 2011;54:1570-1579
  2. Stokes CS, Volmer DA, Grunhage F, Lammert F. Vitamin D in chronic liver disease. Liver Int. 2013;33:338-352
  3. Schiefke I, Fach A, Wiedmann M, Aretin AV, Schenker E, Borte G, Wiese M, Moessner J. Reduced bone mineral density and altered bone turnover markers in patients with non-cirrhotic chronic hepatitis B or C infection. World J Gastroenterol. 2005;11:1843- 1847
  4. Malham M, Jørgensen SP, Ott P, Agnholt J, Vilstrup H, Borre M, Dahlerup JF. Vitamin D deficiency in cirrhosis relates to liver dysfunction rather than aetiology. World J Gastroenterol. 2011;17:922-925. 54 Hussein et al. Hepatitis C Virus Treatment Response and Vitamin D 5. Monegal A, Navasa M, Guañabens N, Peris P, Pons F, Martinez de Osaba MJ, Rimola A, Rodés J, Muñoz-Gómez J. Osteoporosis and bone mineral metabolism disorders in cirrhotic patients referred for orthotopic liver transplantation. Calcif Tissue Int. 1997;60:148-154
  5. Bitetto D, Fattovich G, Fabris C, Ceriani E, Falleti E, Fornasiere E, Pasino M, Ieluzzi D, Cussigh A, Cmet S, Pirisi M, Toniutto P. Complementary role of vitamin D deficiency and the interleukin28B rs12979860 C/T polymorphism in predicting antiviral response in chronic hepatitis C. Hepatology. 2011;53:1118- 1126
  6. European Association for the Study of the Liver. Electronic address: [email protected]. EASL Recommendations on Treatment of Hepatitis C 2016. J Hepatol. 2017;66:153-194
  7. Petta S, Cammà C, Scazzone C, Tripodo C, Di Marco V, Bono A, Cabibi D, Licata G, Porcasi R, Marchesini G, Craxí A. Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C. Hepatology. 2010;51:1158-167
  8. Lange CM, Bojunga J, Ramos-Lopez E, von Wagner M, Hassler A, Vermehren J, Herrmann E, Badenhoop K, Zeuzem S, Sarrazin C. Vitamin D deficiency and a CYP27B1-1260 promoter polymorphism are associated with chronic hepatitis C and poor response to interferon-alfa based therapy. J Hepatol. 2011;54:887- 893
  9. Bitetto D, Fabris C, Fornasiere E, Pipan C, Fumolo E, Cussigh A, Bignulin S, Cmet S, Fontanini E, Falleti E, Martinella R, Pirisi M, Toniutto P. Vitamin D supplementation improves response to antiviral treatment for recurrent hepatitis C. Transpl Int 2011;24:43- 50
  10. Abu Mouch S, Fire